Open-Label Placebo for Major Depressive Disorder: A Pilot Randomized Controlled Trial

被引：132
|
作者：
Kelley, John M. [1 ,2 ,3 ,4 ]
Kaptchuk, Ted J. [2 ,3 ]
Cusin, Cristina [3 ,4 ]
Lipkin, Samuel [3 ,4 ]
Fava, Maurizio [3 ,4 ]
机构：
[1] Endicott Coll, Dept Psychol, Beverly, MA 01915 USA
[2] Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Massachusetts Gen Hosp, Depress Clin & Res Program, Boston, MA USA
来源：
PSYCHOTHERAPY AND PSYCHOSOMATICS | 2012年 / 81卷 / 05期
关键词：
D O I：
10.1159/000337053
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：312 / 314
页数：3
相关论文
共 50 条
  • [31] Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia
    Locher, Cosima
    Nascimento, Antje Frey
    Kirsch, Irving
    Kossowsky, Joe
    Meyer, Andrea
    Gaab, Jens
    [J]. PAIN, 2017, 158 (12) : 2320 - 2328
  • [32] Cilostazol as an adjunctive treatment in major depressive disorder: a pilot randomized, double-blind, and placebo-controlled clinical trial
    Aida Khadivi
    Parnian Shobeiri
    Sara Momtazmaneh
    Farhaneh-Sadat Samsami
    Mohammadreza Shalbafan
    Elham Shirazi
    Shahin Akhondzadeh
    [J]. Psychopharmacology, 2022, 239 : 551 - 559
  • [33] Cilostazol as an adjunctive treatment in major depressive disorder: a pilot randomized, double-blind, and placebo-controlled clinical trial
    Khadivi, Aida
    Shobeiri, Parnian
    Momtazmaneh, Sara
    Samsami, Farhaneh-Sadat
    Shalbafan, Mohammadreza
    Shirazi, Elham
    Akhondzadeh, Shahin
    [J]. PSYCHOPHARMACOLOGY, 2022, 239 (02) : 551 - 559
  • [34] Impact of aripiprazole discontinuation in remitted major depressive disorder: a randomized placebo-controlled trial
    Takeshima, Masahiro
    Umakoshi, Akise
    Omori, Yuki
    Yoshizawa, Kazuhisa
    Ogasawara, Masaya
    Kudo, Mizuki
    Itoh, Yu
    Ayabe, Naoko
    Mishima, Kazuo
    [J]. PSYCHOPHARMACOLOGY, 2024, 241 (08) : 1555 - 1563
  • [35] Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial
    Mao, Jun J.
    Xie, Sharon X.
    Zee, Jarcy
    Soeller, Irene
    Li, Qing S.
    Rockwell, Kenneth
    Amsterdam, Jay D.
    [J]. PHYTOMEDICINE, 2015, 22 (03) : 394 - 399
  • [36] An 8-week, open-label trial of duloxetine for comorbid major depressive disorder and chronic headache
    Volpe, Fernando M.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (09) : 1449 - +
  • [37] Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis
    Schaefer, Michael
    Sahin, Tamay
    Berstecher, Benjamin
    [J]. PLOS ONE, 2018, 13 (03):
  • [38] Open-label placebo reduces fatigue in cancer survivors: a randomized trial
    Zhou, Eric S.
    Hall, Kathryn T.
    Michaud, Alexis L.
    Blackmon, Jaime E.
    Partridge, Ann H.
    Recklitis, Christopher J.
    [J]. SUPPORTIVE CARE IN CANCER, 2019, 27 (06) : 2179 - 2187
  • [39] In Response: Dexmedetomidine versus propofol in dilatation and curettage: An open-label pilot randomized controlled trial
    Tomar, G. S.
    [J]. SAUDI JOURNAL OF ANAESTHESIA, 2016, 10 (01) : 116 - 116
  • [40] Open-label placebo reduces fatigue in cancer survivors: a randomized trial
    Eric S. Zhou
    Kathryn T. Hall
    Alexis L. Michaud
    Jaime E. Blackmon
    Ann H. Partridge
    Christopher J. Recklitis
    [J]. Supportive Care in Cancer, 2019, 27 : 2179 - 2187
12345